The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2021
|
| DOI | 10.1002/14651858.cd010383.pub3 |
| Pubmed ID | |
| Authors |
Janette Greenhalgh, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Marty Chaplin, John A Green |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 201 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 9% |
| Student > Bachelor | 18 | 9% |
| Unspecified | 14 | 7% |
| Student > Ph. D. Student | 10 | 5% |
| Other | 9 | 4% |
| Other | 23 | 11% |
| Unknown | 108 | 54% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 20% |
| Unspecified | 14 | 7% |
| Nursing and Health Professions | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 16 | 8% |
| Unknown | 109 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2021.
All research outputs
#2,781,837
of 26,555,952 outputs
Outputs from Cochrane database of systematic reviews
#5,300
of 13,245 outputs
Outputs of similar age
#72,349
of 474,069 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 167 outputs
Altmetric has tracked 26,555,952 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,245 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 474,069 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.